Vertex Pharma (VRTX) June volatility elevated into data
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Up)Join SI Premium – FREE
Vertex Pharma (Nasdaq: VRTX) PDUFA date for Incivek, (hepatitis C virus treatment) is expected on May 23. May put option implied volatility is at 62, June is at 56, July at 49; compared to its six-month average of 42 according to Track Data.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ExxonMobil (XOM) April weekly option implied volatility into quarter results
- Phillips 66 (PSX) April weekly option implied volatility into quarter results
- BHP Group (BHP) 30-day option implied volatility near low end of range
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
